This Blood test can detect more than 20 types of Cancer

A new study has shown great promise in detecting multiple forms of the deadly disease

There are quite a few cancer-detecting blood tests in development around the world that can detect early biomarkers in the successful detection of the disease — some search for elevated levels of certain proteins, others looked for damaged DNA in white blood cells, while the rest are the on the lookout for irregular platelet RNA profiles.

Recently, I wrote about a new blood test that employs a technology called Parsortix — designed to measure circulating tumor cells (CTCs) in small blood samples. Over 250 people were tested with the new CTC method. When combined with the PSA test, the new method was able to effectively detect aggressive Prostate Cancer with 90% accuracy.

Now, a new blood test has been developed as a result of a scientific collaboration between a private company Grail Inc. and Harvard University’s Dana-Farber Cancer Institute. While the previous techniques to devise a cancer-detecting blood test have had varying levels of success, the newly published study resulted in wide-ranging success.